CLYM SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0002012383-26-003774
CLYM filed a SCHEDULE 13G (schedule 13g) with the SEC on Oct 27, 2026. A Schedule 13G was filed regarding Climb Bio, Inc. (CLYM), indicating a passive ownership position by an institutional or other holder. The stock moved +8.6% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Climb Bio, Inc. (CLYM), indicating a passive ownership position by an institutional or other holder. The filing text provided contains only the EDGAR directory listing and does not disclose specific ownership details.
Key details
How CLYM stock reacted
Close before
$8.81
Oct 26, 2026
First close after
+8.63%
$9.57
5 trading days
+10.56%
$9.74
Since filing
+16.80%
$10.29
✦ Ask GOAX AI about this filing — what it means for CLYM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CLYM?
Click hereFrequently asked questions
What did CLYM file with the SEC on Oct 27, 2026?
CLYM filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Climb Bio, Inc. (CLYM), indicating a passive ownership position by an institutional or other holder. The filing text provided contains only the EDGAR directory listing and does not disclose specific ownership details.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did CLYM stock react to this filing?
CLYM closed at $8.81 before the filing and $9.57 on Oct 27, 2026 (+8.63%). Five trading days later: $9.74 (+10.56%).
Other CLYM SEC filings
- 8-K · SEC filingNov 5, 2026
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- 10-Q · SEC filingNov 5, 2026
- SCHEDULE 13G · SEC filingOct 28, 2026
- 8-K · Fda approvalOct 26, 2026
- 8-K · Fda approvalOct 23, 2026
- 8-K · Fda approvalSep 3, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 14, 2026
- 8-K · SEC filingAug 6, 2026
Get alerts when CLYM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days